MX355012B - Composicion de proteinas resistente a esterilizacion por radiacion. - Google Patents
Composicion de proteinas resistente a esterilizacion por radiacion.Info
- Publication number
- MX355012B MX355012B MX2014013723A MX2014013723A MX355012B MX 355012 B MX355012 B MX 355012B MX 2014013723 A MX2014013723 A MX 2014013723A MX 2014013723 A MX2014013723 A MX 2014013723A MX 355012 B MX355012 B MX 355012B
- Authority
- MX
- Mexico
- Prior art keywords
- radiation
- sterilization
- protein composition
- resistant protein
- resistant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
- A61L17/06—At least partially resorbable materials
- A61L17/10—At least partially resorbable materials containing macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/505—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L28/00—Materials for colostomy devices
- A61L28/0007—Materials for colostomy devices containing macromolecular materials
- A61L28/0026—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/049—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/041—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/143—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01021—Beta-glucosidase (3.2.1.21)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Endocrinology (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
La presente invención se refiere a una composición de proteína que comprende fibrinógeno, un derivado de éter de celulosa y una mezcla de glicina, fenilalanina e histidina, tiene un contenido en agua de nomás de 10% en peso y se esteriliza con radiación, en donde al menos parte del fibrinógeno entra en el interior del derivado de éter de celulosa en el estado de las partículas de fibrinógeno.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012110395 | 2012-05-14 | ||
JP2012110764 | 2012-05-14 | ||
JP2013040594 | 2013-03-01 | ||
PCT/JP2013/063867 WO2013172467A1 (ja) | 2012-05-14 | 2013-05-13 | 放射線滅菌耐性蛋白質組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014013723A MX2014013723A (es) | 2015-08-10 |
MX355012B true MX355012B (es) | 2018-03-28 |
Family
ID=49583865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014013723A MX355012B (es) | 2012-05-14 | 2013-05-13 | Composicion de proteinas resistente a esterilizacion por radiacion. |
Country Status (18)
Country | Link |
---|---|
US (1) | US20150132279A1 (es) |
EP (2) | EP2851083B8 (es) |
JP (2) | JP5872032B2 (es) |
KR (1) | KR102112375B1 (es) |
CN (1) | CN104271145B (es) |
AU (1) | AU2013261307B2 (es) |
BR (1) | BR112014028441B1 (es) |
CA (1) | CA2873655C (es) |
DK (1) | DK2851083T3 (es) |
ES (1) | ES2682024T3 (es) |
HK (1) | HK1204948A1 (es) |
IN (1) | IN2014DN09624A (es) |
MX (1) | MX355012B (es) |
PL (1) | PL2851083T3 (es) |
PT (1) | PT2851083T (es) |
RU (1) | RU2678828C2 (es) |
TW (1) | TWI590836B (es) |
WO (1) | WO2013172467A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107213479B (zh) * | 2017-06-22 | 2018-12-28 | 苏州杰纳生物科技有限公司 | 一种包含过氧化氢酶的组合物及用途 |
WO2020158833A1 (ja) | 2019-01-31 | 2020-08-06 | セルメディシン株式会社 | 無機塩類タンパク複合医療機器 |
US20230041240A1 (en) * | 2020-01-30 | 2023-02-09 | Leukocare Ag | Reduction of Adsorption |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2033046C (en) | 1990-01-12 | 1999-08-03 | Lowell Saferstein | Process for preparing a neutralized oxidized cellulose product and its method of use |
GB9206509D0 (en) | 1992-03-25 | 1992-05-06 | Jevco Ltd | Heteromorphic sponges containing active agents |
AU682894B2 (en) * | 1993-10-28 | 1997-10-23 | Institut National De La Recherche Agronomique | Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man |
JP3648573B2 (ja) * | 1995-03-29 | 2005-05-18 | 第一工業製薬株式会社 | カルボキシメチルセルロースナトリウム塩の溶解方法 |
US6551794B1 (en) * | 1995-11-09 | 2003-04-22 | E. R. Squibb & Sons, Inc. | Stable biotinylated biomolecule composition |
US5730933A (en) * | 1996-04-16 | 1998-03-24 | Depuy Orthopaedics, Inc. | Radiation sterilization of biologically active compounds |
US5968895A (en) * | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
US6103266A (en) * | 1998-04-22 | 2000-08-15 | Tapolsky; Gilles H. | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
US6056970A (en) * | 1998-05-07 | 2000-05-02 | Genzyme Corporation | Compositions comprising hemostatic compounds and bioabsorbable polymers |
WO2000029041A1 (de) * | 1998-11-18 | 2000-05-25 | Aventis Behring Gmbh | Stabilisierte proteinzubereitungen für einen gewebekleber |
GB2344519B (en) * | 1998-12-07 | 2004-05-19 | Johnson & Johnson Medical Ltd | Sterile therapeutic compositions |
DE10022092A1 (de) * | 2000-05-08 | 2001-11-15 | Aventis Behring Gmbh | Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung |
US7252799B2 (en) * | 2001-08-31 | 2007-08-07 | Clearant, Inc. | Methods for sterilizing preparations containing albumin |
US6749851B2 (en) * | 2001-08-31 | 2004-06-15 | Clearant, Inc. | Methods for sterilizing preparations of digestive enzymes |
WO2003028654A2 (en) * | 2001-10-03 | 2003-04-10 | Woolverton Christopher J | Storage-stable human fibrinogen solutions |
DE60328909D1 (de) * | 2002-11-20 | 2009-10-01 | Arriva Prometic Inc | Zusammensetzung zur behandlung von ichthyosis unter verwendung von antitrypsin |
DK1809343T3 (da) * | 2004-10-20 | 2012-11-26 | Ethicon Inc | Forstærket absorberbar hæmostatisk flerlagssårforbinding samt fremstillingsfremgangsmåde |
GB0505975D0 (en) * | 2005-03-23 | 2005-04-27 | Queen Mary & Westfield College | Novel use of peptide |
WO2008117746A1 (ja) * | 2007-03-22 | 2008-10-02 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | 固体状フィブリノゲン製剤 |
EP2143440A1 (fr) * | 2008-07-09 | 2010-01-13 | Sanofi Pasteur | Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués |
JP5555928B2 (ja) | 2009-08-28 | 2014-07-23 | 日本バイリーン株式会社 | 酵素含有ナノファイバーの製造方法、酵素含有ナノファイバー、この酵素含有ナノファイバーを含む不織布及びこの不織布を用いた反応装置 |
RU2535869C2 (ru) * | 2010-01-28 | 2014-12-20 | Эдванст Бионутришн Корпорейшн | Сухая стекловидная композиция для стабилизации и защиты биологически активного материала и способ ее получения |
-
2013
- 2013-05-13 MX MX2014013723A patent/MX355012B/es active IP Right Grant
- 2013-05-13 WO PCT/JP2013/063867 patent/WO2013172467A1/ja active Application Filing
- 2013-05-13 TW TW102116957A patent/TWI590836B/zh not_active IP Right Cessation
- 2013-05-13 PL PL13790434T patent/PL2851083T3/pl unknown
- 2013-05-13 RU RU2014150497A patent/RU2678828C2/ru active
- 2013-05-13 DK DK13790434.8T patent/DK2851083T3/en active
- 2013-05-13 EP EP13790434.8A patent/EP2851083B8/en active Active
- 2013-05-13 PT PT13790434T patent/PT2851083T/pt unknown
- 2013-05-13 EP EP18167342.7A patent/EP3366301A1/en not_active Withdrawn
- 2013-05-13 CN CN201380025293.2A patent/CN104271145B/zh active Active
- 2013-05-13 JP JP2014515697A patent/JP5872032B2/ja active Active
- 2013-05-13 CA CA2873655A patent/CA2873655C/en active Active
- 2013-05-13 US US14/400,978 patent/US20150132279A1/en not_active Abandoned
- 2013-05-13 IN IN9624DEN2014 patent/IN2014DN09624A/en unknown
- 2013-05-13 BR BR112014028441-5A patent/BR112014028441B1/pt not_active IP Right Cessation
- 2013-05-13 KR KR1020147031797A patent/KR102112375B1/ko active IP Right Grant
- 2013-05-13 ES ES13790434.8T patent/ES2682024T3/es active Active
- 2013-05-13 AU AU2013261307A patent/AU2013261307B2/en not_active Ceased
-
2015
- 2015-06-15 HK HK15105625.5A patent/HK1204948A1/xx not_active IP Right Cessation
- 2015-11-05 JP JP2015217255A patent/JP6317307B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
BR112014028441A2 (pt) | 2017-06-27 |
RU2678828C2 (ru) | 2019-02-04 |
EP3366301A1 (en) | 2018-08-29 |
EP2851083A4 (en) | 2015-05-06 |
MX2014013723A (es) | 2015-08-10 |
KR102112375B1 (ko) | 2020-05-18 |
CA2873655A1 (en) | 2013-11-21 |
KR20150020539A (ko) | 2015-02-26 |
CN104271145B (zh) | 2017-01-18 |
EP2851083B8 (en) | 2018-08-08 |
AU2013261307B2 (en) | 2017-12-21 |
BR112014028441B1 (pt) | 2021-04-27 |
HK1204948A1 (en) | 2015-12-11 |
JP5872032B2 (ja) | 2016-03-01 |
WO2013172467A1 (ja) | 2013-11-21 |
JP2016053063A (ja) | 2016-04-14 |
IN2014DN09624A (es) | 2015-07-31 |
US20150132279A1 (en) | 2015-05-14 |
JP6317307B2 (ja) | 2018-04-25 |
CN104271145A (zh) | 2015-01-07 |
AU2013261307A1 (en) | 2014-12-04 |
JPWO2013172467A1 (ja) | 2016-01-12 |
TWI590836B (zh) | 2017-07-11 |
CA2873655C (en) | 2021-04-06 |
EP2851083B1 (en) | 2018-06-20 |
TW201350146A (zh) | 2013-12-16 |
EP2851083A1 (en) | 2015-03-25 |
RU2014150497A (ru) | 2016-07-10 |
PL2851083T3 (pl) | 2019-04-30 |
PT2851083T (pt) | 2018-10-18 |
DK2851083T3 (en) | 2018-08-27 |
ES2682024T3 (es) | 2018-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL243752A0 (en) | Multispecific antibodies, preparations containing them and their uses | |
EP3043826A4 (en) | Polynucleotide compositions containing amino acids | |
GEP20196964B (en) | Pest control composition including novel iminopyridine derivative | |
MX2016003843A (es) | Inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos. | |
UA116091C2 (uk) | Способи та композиції для боротьби з бур'янами | |
IN2014DN08481A (es) | ||
MX2016014862A (es) | Her3 / her2 anticuerpos biespecificos que se unen a la horquilla beta de her3 y al dominio ii de her2. | |
AU2012209332A8 (en) | Methods and compositions for preparing noribogaine from voacangine | |
EP3068833A4 (en) | Polymeric compositions comprising polyisoprene | |
EP3065771A4 (en) | Methods and compositions for sustained immunotherapy | |
GB2564187B (en) | Diesel fuel composition containing additive | |
EP3023477A4 (en) | Composition, and light-emitting element using same | |
EP3019553A4 (en) | Azide-based crosslinking agents | |
GB2562605B (en) | Diesel fuel composition containing additive | |
GB2562876B (en) | Diesel fuel composition containing additive | |
GB2562608B (en) | Diesel fuel composition containing additive | |
GEP201706760B (en) | Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same | |
EP2848648A4 (en) | RUBBER ADDITIVE AND RUBBER COMPOSITION OBTAINED BY ITS MIXTURE | |
EP3339376A4 (en) | RESIN ADDITIVE COMPOSITION AND SYNTHETIC RESIN COMPOSITION USING THE SAME | |
MX363530B (es) | Compuesto de benzoxaborol tricíclico, método de preparación y uso del mismo. | |
BR112018003173A2 (pt) | lactama encapsulada, aditivo, composição e método de encapsulamento de uma lactama | |
NZ630549A (en) | N-ethyl-4-hydroxyl-1-methyl-5- (methyl(2,3,4,5,6-pentahydroxyhexyl) amino) -2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide | |
MX2015008588A (es) | Composiciones y metodos para la transfeccion de polinucleótidos. | |
EP3019467A4 (en) | Dihydroxyphenyl neurotransmitter compounds, compositions and methods | |
SG11201509341VA (en) | Fuel additive composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: TEIJIN LIMITED |
|
FG | Grant or registration |